Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Enhancing Diabetes Care by Treating Insomnia

Study ID: NCT07062406
Start Date: 2026-04-01
End Date: 2027-01-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Cognitive Behavioral Therapy for Insomnia

Usual care for diabetes management

Usual care for treatment of insomnia

Sponsor

Tulane University

Source: clinicaltrials.gov

Share:
Add to list

GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

Study ID: NCT07221214
Start Date: 2026-02-06
End Date: 2030-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

Semaglutide (Rybelsus®)

Placebo

Sponsor

Vanderbilt University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of the FYNA Research OPM MEG Device for Locating Epileptic Foci as Part of Pre-surgical Assessment of Epilepsy

Study ID: NCT07281222
Start Date: 2026-03
End Date: 2030-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

ME OPM

MEG SQUID

Sponsor

Civil Hospices of Lyon

Source: clinicaltrials.gov

Share:
Add to list

A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection

Study ID: NCT03038802
Start Date: 2026-03-01
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Therapeutic hepatitis B vaccine

Commercial Hepatitis B vaccine

Sponsor

Vaxine Pty Ltd

Source: clinicaltrials.gov

Share:
Add to list

Person-Centred AI Support in Interdisciplinary Rehabilitation for Chronic Pain

Study ID: NCT07081737
Start Date: 2026-05-01
End Date: 2029-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

Interdisciplinary treatment (IDT) + Clinical Decision Support System (CDSS)

Interdisciplinary treatment (IDT)

Sponsor

Bjorn The

Source: clinicaltrials.gov

Share:
Add to list

A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer

Study ID: NCT06888102
Start Date: 2026-04
End Date: 2029-10
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

20

Intervention / Treatment

Neoadjuvant Epigenetic Therapy

Sponsor

Edwin Posadas, MD

Source: clinicaltrials.gov

Share:
Add to list

Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment

Study ID: NCT07275216
Start Date: 2026-07-01
End Date: 2027-11-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

23

Intervention / Treatment

Biospecimen Collection

Brentuximab Vedotin

Computed Tomography

Dacarbazine

Echocardiography Test

Gemcitabine

Pembrolizumab

Physical Performance Testing

Positron Emission Tomography

Pulmonary Function Test

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study

Study ID: NCT07313072
Start Date: 2026-03
End Date: 2027-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

10

Intervention / Treatment

Topical 2% Tofacitinib

Sponsor

Hexsel Dermatology Clinic

Source: clinicaltrials.gov

Share:
Add to list

Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer

Study ID: NCT07310433
Start Date: 2026-06-01
End Date: 2030-10-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Dapagliflozin (10mg Tab)

standard medical care (ADT + NHA)

Sponsor

The NA

Source: clinicaltrials.gov

Share:
Add to list

The Cognitive-Functional Relationship in Geriatric Hand-Forearm Injuries

Study ID: NCT07379229
Start Date: 2026-02-23
End Date: 2026-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

34

Intervention / Treatment

Questionnaire and Physical Exam

Sponsor

Pamukkale University

Source: clinicaltrials.gov

Share:
Add to list